Publications

Search our bibliography using the filters on the right-hand side.

Displaying 1 through 20 of 20 publications.

Rosenow F, Winter Y, Leunikava I, Brunnert M, Sutphin J, Boeri M, Villani F, Brandt C. Patient and physician preferences in epilepsy monotherapy in a real world study (VOTE): evidence from discrete choice experiments. Poster presented at the 2020 Virtual 74th American Epilepsy Society (AES) Annual Meeting; December 4, 2020.

Dorgali MV, Longo A, Vass C, Shields G, Harrison R, Boeri M. Exploring Antimicrobial Resistance (AMR) from a societal perspective: preferences and welfare impacts in the United Kingdom. Poster presented at the Virtual ISPOR Europe 2020 Conference; November 2020. [abstract] Value Health. 2020 Dec; 23(S2).

Boeri M, Sutphin J, Hauber B, Cappelleri JC, Romero W, DiBonaventura M. Identifying patient preferences for systemic atopic dermatitis treatments using a discrete choice experiment. Poster presented at the 2020 Virtual 29th European Academy of Dermatology and Venerology Congress; October 28, 2020.

McMichael AJ, Rolison JJ, Boeri M, Kee F. The needs of many vs. the needs of few: is society willing to pay for stratified medicine. Poster presented at the 2020 36th ICPE International Virtual Conference on Pharmacoepidemiology & Therapeutic Risk Management; September 16, 2020.

Turk DC, Boeri M, Abraham L, Atkinson J, Bushmakin A, Cappelleri JC, Hauber B, Klein K, Russo L, Viktrup L, Walsh DA. Patient preferences for osteoarthritis pain and chronic low back pain treatments in the United States: a discrete-choice experiment. Osteoarthritis Cartilage. 2020 Sep 1;28(9):1202-13. doi: 10.1016/j.joca.2020.06.006

Graham-Clarke PL, Hauber B, Boeri M, Leonardi F, Burge RT, Fernandez M, Tockhorn-Heidenreich A, Florez S. Patient preferences for biologic and biosimilar osteoporosis treatments in Colombia. Patient Prefer Adherence. 2020 Jun 23;2020(14):1049-64. doi: 10.2147/PPA.S250745

Minnis AM, Atujuna M, Browne EN, Ndwayana S, Hartmann M, Sindelo S, Ngcwayi N, Boeri M, Mansfield C, Bekker L-G, Montgomery ET. Preferences for long‐acting Pre‐Exposure Prophylaxis (PrEP) for HIV prevention among South African youth: results of a discrete choice experiment. J Int AIDS Soc. 2020 Jun 16;23:e25528. doi: 10.1002/jia2.25528

Boeri M, Heidenreich S, Marshall D. We are not all the same: the state of practice in accounting for preference heterogeneity. Presented at the 2020 ISPOR Virtual Conference; May 18, 2020.

Vass C, Boeri M, Poulos C. Association between access device and stated preferences for health care. Poster presented at the 2020 ISPOR Virtual Conference; May 2020. [abstract] Value Health. 2020 May 1;. doi: 10.1016/j.jval.2020.04.1183

Browne EN, Montgomery ET, Mansfield C, Boeri M, Mange B, Beksinska M, Schwartz JL, Clark MR, Doncel GF, Smit J, Chirenje ZM, van der Straten A. Efficacy is not everything: eliciting women's preferences for a vaginal HIV prevention product using a discrete-choice experiment. AIDS Behav. 2020 May;24(5):1443-51. doi: 10.1007/s10461-019-02715-1

Poulos C, Vass C, Klein K, Boeri M. Scope tests in health care discrete choice experiments. Poster presented at the 2020 ISPOR Virtual Conference; May 2020. [abstract] Value Health. 2020 May 1; 23(Suppl 1):S320. doi: 10.1016/j.jval.2020.04.094

Mansfield C, Boeri M, Coulter J, Baranowski E, Sparks S, Hamed A. Preferences for genetic tests: trading off speed of diagnosis, availability of treatment, and cost. Poster presented at the 2020 ISPOR Virtual Conference; May 2020. [abstract] Value Health. 2020 May 1; 23(Suppl 1):S345. doi: 10.1016/j.jval.2020.04.094

Boeri M, Abraham L, Hauber B, Atkinson J, Bushmakin AG, Cappelleri JC, Russo L, Viktrup L, Klein K, Walsh D, Turk D. Exploring heterogeneity in preferences for attributes of pharmaceutical treatments for osteoarthritis and chronic low back pain in the United States: a latent class approach. Presented at the 2020 ISPOR Virtual Conference; May 18, 2020. [abstract] Value Health. 2020 May 1; 23(Suppl 1):S325. Previously presented at the ISPOR 2019 European Conference. doi: 10.1016/j.jval.2020.04.371

Sutphin J, Boeri M, Hauber B, Purdum AG. Physician preferences for CAR T therapy: trading off benefits, risks, and time to infusion in the treatment of diffuse large B-cell lymphoma. Poster presented at the 2020 ISPOR Virtual Conference; May 2020. [abstract] Value Health. 2020 May 1; 23(Suppl 1):S19. doi: 10.1016/j.jval.2020.04.094

Sutphin J, Mansfield C, DiSantostefano R, Klein K, Boeri M. Getting the most out of latent-class analysis in modeling preferences for an interception treatment in Type 1 diabetes. Poster presented at the 2020 ISPOR Virtual Conference; May 2020. [abstract] Value Health. 2020 May 1; 23(Suppl 1):S125. doi: 10.1016/j.jval.2020.04.371